Paragon's hub-and-spoke biotech model yields another reverse merger
BioPharma
Source: biopharmadive.com
Carl Dambkowski News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Carl Dambkowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Carl Dambkowski Today - Breaking & Trending Today
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
Preclinical data with APG808 demonstrate the potential for improved dosing over other treatment options in development, including the potential for dosing every six- or eight- weeks compared to dosing...
Source: marketscreener.com
LianBio Announces Infigratinib Approved Under Special Named
SHANGHAI, China and PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative...
Source: globenewswire.com
LianBio Announces Infigratinib Approved Under Special Named Patient Program for the Treatment of Cholangiocarcinoma in the Pilot Zone of Hainan Province in China
LianBio Announces Infigratinib Approved Under Special Named Patient Program for the Treatment of Cholangiocarcinoma in the Pilot Zone of Hainan Province in China - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com